{"id":5036,"date":"2025-05-22T17:41:27","date_gmt":"2025-05-22T17:41:27","guid":{"rendered":"https:\/\/www.podermexico.mx\/?p=5036"},"modified":"2025-05-22T17:41:29","modified_gmt":"2025-05-22T17:41:29","slug":"pfizer-analiza-expandir-su-inversion-en-investigacion-clinica-en-mexico","status":"publish","type":"post","link":"https:\/\/www.podermexico.mx\/?p=5036","title":{"rendered":"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">La farmac\u00e9utica estadounidense <strong>Pfizer<\/strong> eval\u00faa la posibilidad de <strong>triplicar sus estudios cl\u00ednicos en M\u00e9xico<\/strong>, lo que implicar\u00eda un incremento significativo en la inversi\u00f3n dentro del pa\u00eds. Sin embargo, la empresa se\u00f1ala que este crecimiento depender\u00e1 de la <strong>certeza jur\u00eddica y la agilizaci\u00f3n de los procesos regulatorios<\/strong>, aspectos clave para fortalecer el sector de la investigaci\u00f3n m\u00e9dica.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Gabriela D\u00e1vila, directora regional de Investigaci\u00f3n Cl\u00ednica de Pfizer para Europa, Canad\u00e1 y Am\u00e9rica Latina<\/strong>, subray\u00f3 que el pa\u00eds tiene \u00e1reas de oportunidad en la reducci\u00f3n de los tiempos de aprobaci\u00f3n de protocolos y la importaci\u00f3n de insumos, que actualmente pueden extenderse entre <strong>300 y 400 d\u00edas<\/strong>. <strong>&#8220;M\u00e9xico, desde el punto de vista de Pfizer, est\u00e1 dentro de los primeros 20 pa\u00edses y para subir de nivel necesitamos competir con tiempos m\u00e1s competitivos&#8221;<\/strong>, afirm\u00f3 en entrevista.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Si se logra reducir los plazos regulatorios a un rango de <strong>45 a 90 d\u00edas<\/strong>, M\u00e9xico podr\u00eda consolidarse entre las naciones l\u00edderes en <strong>investigaci\u00f3n cl\u00ednica a nivel mundial<\/strong>, favoreciendo el desarrollo de nuevos tratamientos y terapias innovadoras.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Actualmente, <strong>Pfizer mantiene 25 estudios cl\u00ednicos activos<\/strong> en el pa\u00eds y tiene <strong>otros 23 en proceso de aprobaci\u00f3n<\/strong>, lo que le permitir\u00eda cerrar el a\u00f1o con <strong>hasta 48 protocolos en distintas fases de investigaci\u00f3n<\/strong>. Las \u00e1reas terap\u00e9uticas incluyen <strong>oncolog\u00eda, inflamaci\u00f3n, inmunolog\u00eda, enfermedades infecciosas y medicina interna<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En los \u00faltimos cuatro a\u00f1os, la compa\u00f1\u00eda ha invertido m\u00e1s de <strong>64 millones de d\u00f3lares<\/strong> en investigaci\u00f3n cl\u00ednica en M\u00e9xico, contribuyendo a la generaci\u00f3n de empleos directos e indirectos. A futuro, la empresa proyecta alinearse con la meta del <strong>Plan M\u00e9xico<\/strong>, que busca atraer <strong>2,000 millones de d\u00f3lares<\/strong> en inversi\u00f3n para estudios cl\u00ednicos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">D\u00e1vila enfatiz\u00f3 la importancia de trabajar en equipo entre <strong>industria, gobierno y academia<\/strong> para mejorar la infraestructura, eliminar rezagos regulatorios y consolidar un entorno favorable para la investigaci\u00f3n cient\u00edfica. <strong>&#8220;Lo veo posible siempre y cuando todos hablemos el mismo idioma y trabajemos en pro de la investigaci\u00f3n cl\u00ednica&#8221;<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La farmac\u00e9utica estadounidense Pfizer eval\u00faa la posibilidad de triplicar sus estudios cl\u00ednicos en M\u00e9xico, lo que implicar\u00eda un incremento significativo en la inversi\u00f3n dentro del pa\u00eds. Sin embargo, la empresa se\u00f1ala que este crecimiento depender\u00e1 de la certeza jur\u00eddica y la agilizaci\u00f3n de los procesos regulatorios, aspectos clave para fortalecer el sector de la investigaci\u00f3n m\u00e9dica. Gabriela D\u00e1vila, directora regional &hellip;<\/p>\n","protected":false},"author":7,"featured_media":5037,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[68],"tags":[104,577],"class_list":["post-5036","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salud","tag-mexico","tag-pfizer"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Pfizer eval\u00faa expandir estudios cl\u00ednicos en M\u00e9xico, pero la certeza jur\u00eddica y la agilizaci\u00f3n de tr\u00e1mites regulatorios ser\u00e1n clave para atraer mayor inversi\u00f3n al pa\u00eds.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Poder M\u00e9xico\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.podermexico.mx\/?p=5036\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"es_MX\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Poder M\u00e9xico - Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico - Poder M\u00e9xico\" \/>\n\t\t<meta property=\"og:description\" content=\"Pfizer eval\u00faa expandir estudios cl\u00ednicos en M\u00e9xico, pero la certeza jur\u00eddica y la agilizaci\u00f3n de tr\u00e1mites regulatorios ser\u00e1n clave para atraer mayor inversi\u00f3n al pa\u00eds.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.podermexico.mx\/?p=5036\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-05-22T17:41:27+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-05-22T17:41:29+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico - Poder M\u00e9xico\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Pfizer eval\u00faa expandir estudios cl\u00ednicos en M\u00e9xico, pero la certeza jur\u00eddica y la agilizaci\u00f3n de tr\u00e1mites regulatorios ser\u00e1n clave para atraer mayor inversi\u00f3n al pa\u00eds.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036#blogposting\",\"name\":\"Pfizer analiza expandir su inversi\\u00f3n en investigaci\\u00f3n cl\\u00ednica en M\\u00e9xico - Poder M\\u00e9xico\",\"headline\":\"Pfizer analiza expandir su inversi\\u00f3n en investigaci\\u00f3n cl\\u00ednica en M\\u00e9xico\",\"author\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/pfizer-mexico.jpg\",\"width\":1080,\"height\":720},\"datePublished\":\"2025-05-22T17:41:27-06:00\",\"dateModified\":\"2025-05-22T17:41:29-06:00\",\"inLanguage\":\"es-MX\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036#webpage\"},\"articleSection\":\"Salud, M\\u00e9xico, Pfizer\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.podermexico.mx\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=68#listItem\",\"name\":\"Salud\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=68#listItem\",\"position\":2,\"name\":\"Salud\",\"item\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=68\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036#listItem\",\"name\":\"Pfizer analiza expandir su inversi\\u00f3n en investigaci\\u00f3n cl\\u00ednica en M\\u00e9xico\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036#listItem\",\"position\":3,\"name\":\"Pfizer analiza expandir su inversi\\u00f3n en investigaci\\u00f3n cl\\u00ednica en M\\u00e9xico\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?cat=68#listItem\",\"name\":\"Salud\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#organization\",\"name\":\"Poder M\\u00e9xico\",\"description\":\"Donde los l\\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\\u00edtica y los negocios\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7\",\"name\":\"Poder M\\u00e9xico\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6873d270747c7f511ab0e491b4ef59ff185c68a5912118c90f83cdcd498e434b?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Poder M\\u00e9xico\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036#webpage\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036\",\"name\":\"Pfizer analiza expandir su inversi\\u00f3n en investigaci\\u00f3n cl\\u00ednica en M\\u00e9xico - Poder M\\u00e9xico\",\"description\":\"Pfizer eval\\u00faa expandir estudios cl\\u00ednicos en M\\u00e9xico, pero la certeza jur\\u00eddica y la agilizaci\\u00f3n de tr\\u00e1mites regulatorios ser\\u00e1n clave para atraer mayor inversi\\u00f3n al pa\\u00eds.\",\"inLanguage\":\"es-MX\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?author=7#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/pfizer-mexico.jpg\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036\\\/#mainImage\",\"width\":1080,\"height\":720},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/?p=5036#mainImage\"},\"datePublished\":\"2025-05-22T17:41:27-06:00\",\"dateModified\":\"2025-05-22T17:41:29-06:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#website\",\"url\":\"https:\\\/\\\/www.podermexico.mx\\\/\",\"name\":\"Poder M\\u00e9xico\",\"description\":\"Donde los l\\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\\u00edtica y los negocios\",\"inLanguage\":\"es-MX\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.podermexico.mx\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico - Poder M\u00e9xico","description":"Pfizer eval\u00faa expandir estudios cl\u00ednicos en M\u00e9xico, pero la certeza jur\u00eddica y la agilizaci\u00f3n de tr\u00e1mites regulatorios ser\u00e1n clave para atraer mayor inversi\u00f3n al pa\u00eds.","canonical_url":"https:\/\/www.podermexico.mx\/?p=5036","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.podermexico.mx\/?p=5036#blogposting","name":"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico - Poder M\u00e9xico","headline":"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico","author":{"@id":"https:\/\/www.podermexico.mx\/?author=7#author"},"publisher":{"@id":"https:\/\/www.podermexico.mx\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.podermexico.mx\/wp-content\/uploads\/2025\/05\/pfizer-mexico.jpg","width":1080,"height":720},"datePublished":"2025-05-22T17:41:27-06:00","dateModified":"2025-05-22T17:41:29-06:00","inLanguage":"es-MX","mainEntityOfPage":{"@id":"https:\/\/www.podermexico.mx\/?p=5036#webpage"},"isPartOf":{"@id":"https:\/\/www.podermexico.mx\/?p=5036#webpage"},"articleSection":"Salud, M\u00e9xico, Pfizer"},{"@type":"BreadcrumbList","@id":"https:\/\/www.podermexico.mx\/?p=5036#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx#listItem","position":1,"name":"Home","item":"https:\/\/www.podermexico.mx","nextItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?cat=68#listItem","name":"Salud"}},{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?cat=68#listItem","position":2,"name":"Salud","item":"https:\/\/www.podermexico.mx\/?cat=68","nextItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?p=5036#listItem","name":"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?p=5036#listItem","position":3,"name":"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico","previousItem":{"@type":"ListItem","@id":"https:\/\/www.podermexico.mx\/?cat=68#listItem","name":"Salud"}}]},{"@type":"Organization","@id":"https:\/\/www.podermexico.mx\/#organization","name":"Poder M\u00e9xico","description":"Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios","url":"https:\/\/www.podermexico.mx\/"},{"@type":"Person","@id":"https:\/\/www.podermexico.mx\/?author=7#author","url":"https:\/\/www.podermexico.mx\/?author=7","name":"Poder M\u00e9xico","image":{"@type":"ImageObject","@id":"https:\/\/www.podermexico.mx\/?p=5036#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/6873d270747c7f511ab0e491b4ef59ff185c68a5912118c90f83cdcd498e434b?s=96&d=mm&r=g","width":96,"height":96,"caption":"Poder M\u00e9xico"}},{"@type":"WebPage","@id":"https:\/\/www.podermexico.mx\/?p=5036#webpage","url":"https:\/\/www.podermexico.mx\/?p=5036","name":"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico - Poder M\u00e9xico","description":"Pfizer eval\u00faa expandir estudios cl\u00ednicos en M\u00e9xico, pero la certeza jur\u00eddica y la agilizaci\u00f3n de tr\u00e1mites regulatorios ser\u00e1n clave para atraer mayor inversi\u00f3n al pa\u00eds.","inLanguage":"es-MX","isPartOf":{"@id":"https:\/\/www.podermexico.mx\/#website"},"breadcrumb":{"@id":"https:\/\/www.podermexico.mx\/?p=5036#breadcrumblist"},"author":{"@id":"https:\/\/www.podermexico.mx\/?author=7#author"},"creator":{"@id":"https:\/\/www.podermexico.mx\/?author=7#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.podermexico.mx\/wp-content\/uploads\/2025\/05\/pfizer-mexico.jpg","@id":"https:\/\/www.podermexico.mx\/?p=5036\/#mainImage","width":1080,"height":720},"primaryImageOfPage":{"@id":"https:\/\/www.podermexico.mx\/?p=5036#mainImage"},"datePublished":"2025-05-22T17:41:27-06:00","dateModified":"2025-05-22T17:41:29-06:00"},{"@type":"WebSite","@id":"https:\/\/www.podermexico.mx\/#website","url":"https:\/\/www.podermexico.mx\/","name":"Poder M\u00e9xico","description":"Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios","inLanguage":"es-MX","publisher":{"@id":"https:\/\/www.podermexico.mx\/#organization"}}]},"og:locale":"es_MX","og:site_name":"Poder M\u00e9xico - Donde los l\u00edderes definen el futuro, exploramos tendencias y desciframos el mundo de la pol\u00edtica y los negocios","og:type":"article","og:title":"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico - Poder M\u00e9xico","og:description":"Pfizer eval\u00faa expandir estudios cl\u00ednicos en M\u00e9xico, pero la certeza jur\u00eddica y la agilizaci\u00f3n de tr\u00e1mites regulatorios ser\u00e1n clave para atraer mayor inversi\u00f3n al pa\u00eds.","og:url":"https:\/\/www.podermexico.mx\/?p=5036","article:published_time":"2025-05-22T17:41:27+00:00","article:modified_time":"2025-05-22T17:41:29+00:00","twitter:card":"summary_large_image","twitter:title":"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico - Poder M\u00e9xico","twitter:description":"Pfizer eval\u00faa expandir estudios cl\u00ednicos en M\u00e9xico, pero la certeza jur\u00eddica y la agilizaci\u00f3n de tr\u00e1mites regulatorios ser\u00e1n clave para atraer mayor inversi\u00f3n al pa\u00eds."},"aioseo_meta_data":{"post_id":"5036","title":null,"description":"Pfizer eval\u00faa expandir estudios cl\u00ednicos en M\u00e9xico, pero la certeza jur\u00eddica y la agilizaci\u00f3n de tr\u00e1mites regulatorios ser\u00e1n clave para atraer mayor inversi\u00f3n al pa\u00eds.","keywords":null,"keyphrases":{"focus":{"keyphrase":"Investigaci\u00f3n cl\u00ednica en M\u00e9xico","score":44,"analysis":{"keyphraseInTitle":{"score":9,"maxScore":9,"error":0},"keyphraseInDescription":{"score":3,"maxScore":9,"error":1},"keyphraseLength":{"score":6,"maxScore":9,"error":1,"length":7},"keyphraseInURL":{"score":1,"maxScore":5,"error":1},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInSubHeadings":[],"keyphraseInImageAlt":[],"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2025-05-22 17:41:29","updated":"2025-07-13 06:32:50","seo_analyzer_scan_date":null,"focus_keyword":"Investigaci\u00f3n cl\u00ednica en M\u00e9xico","additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.podermexico.mx\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.podermexico.mx\/?cat=68\" title=\"Salud\">Salud<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tPfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.podermexico.mx"},{"label":"Salud","link":"https:\/\/www.podermexico.mx\/?cat=68"},{"label":"Pfizer analiza expandir su inversi\u00f3n en investigaci\u00f3n cl\u00ednica en M\u00e9xico","link":"https:\/\/www.podermexico.mx\/?p=5036"}],"_links":{"self":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts\/5036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5036"}],"version-history":[{"count":1,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts\/5036\/revisions"}],"predecessor-version":[{"id":5038,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/posts\/5036\/revisions\/5038"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=\/wp\/v2\/media\/5037"}],"wp:attachment":[{"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.podermexico.mx\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}